RegisterLogin

CDK8-IN-16

CAT: 0804-HY-171174-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-171174-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
CDK8-IN-16 (Compound 51) is an orally active dual inhibitor for CDK8 and CDK19 wih IC50 of 5.1 nM and 5.6 nM. CDK8-IN-16 inhibits the phospho-STAT1SER727 with an IC50 of 17.9 nM in SW620 cell, inhibits WNT signaling pathway with an IC50 of 7.2 nM in 7dF3 cell. CDK8-IN-16 exhibits good pharmacokinetic characteristics in rat models with an oral bioavailability of 57%[1].
CAS Number
[1860885-61-5]
UNSPSC
12352005
Target
CDK; STAT; Wnt
Related Pathways
Cell Cycle/DNA Damage; JAK/STAT Signaling; Stem Cell/Wnt
Field of Research
Cancer
Smiles
O=C(N1CC(C1)OC)C2=NC3=C(C4=CC=C(C5=CN(C)N=C5)C=C4)C=NC(N)=C3C=C2
Molecular Formula
C23H22N6O2
Molecular Weight
414.46
References & Citations
[1]Mallinger A, et al., 2,8-Disubstituted-1,6-Naphthyridines and 4,6-Disubstituted-Isoquinolines with Potent, Selective Affinity for CDK8/19. ACS Med Chem Lett. 2016 Mar 28;7 (6) :573-8.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK19; CDK8

Related Products

CatalogName
HY-162293CDK8-IN-14
HY-169541CDK8-IN-18
HY-148561-01CDK8-IN-12
HY-147717CDK8-IN-7
HY-111463-01CDK8-IN-3
HY-162600CDK8-IN-15
HY-103492-01CDK8-IN-1
HY-151463-01CDK8-IN-11
HY-147716CDK8-IN-6
HY-169633-01CDK8-IN-17

Alternative Products

CatalogName
521352-01CDK8
M36414-01CDK8-IN-12
534566-01Cdk8 discontinued
501359CDK8, CT
MBS7130291-01CDK8 Antibody
T10740-01CDK8-IN-1
DF2309-BPCDK8 Peptide
MBS5804801CDK8-IN-6
MBS5804998CDK8-IN-5
MBS5806358CDK8-IN-10

Popular Products